Trent, died days before Christmas after her flight to the Dominican Republic was forced to divert to Puerto Rico ...

Teacher and A Level examiner Catherine Mills, 53, suffered multiple injuries after 19-year old motorist Leah MacKinnon pulled ...

Total revenue rose 11 per cent to $28bn (£12.98bn) in the first half of the year, driven by double-digit growth in Oncology and BioPharmaceuticals, the pharmaceutical giant told markets this morning ...

New food hygiene ratings have been awarded to 15 of Cheshire East’s establishments, the Food Standards Agency’s website shows ...

Teacher Catherine Mills was left with lifechanging injuries after the teenage driver failed to see her when she pulled out at ...

AstraZeneca said on Thursday its experimental therapy, gefurulimab, met the primary goal and all secondary endpoints in a ...

British-Swedish pharmaceutical company AstraZeneca announced a $50 billion investment in the U.S. this week, with the Trump administration claiming some credit due to its tariff policy and Presiden… ...

British biopharmaceutical giant AstraZeneca plans to invest $50 billion in the United States by 2030, expanding its presence in the company's largest market.

British-Swedish pharmaceutical company AstraZeneca is expanding its presence in the US in a bid to boost sales in its largest market.

AstraZeneca said Tuesday it's planning to invest $50 billion in expanding its manufacturing and research presence in the U.S. by 2030, as worries about tariffs loom over the industry.

AstraZeneca plans to construct a multi-billion dollar manufacturing center focused on chronic diseases in Virginia within the next five years.

AstraZeneca’s plans to get an amyloidosis drug to market look further out of reach after the pharma’s anti-fibril antibody failed to reduce deaths and hospitalizations in a key phase 3 study ...